Participants and potential participants
This section of the website is primarily for people who have already decided to participate in the trial or who have received letters inviting them to participate.
Why am I being invited to take part?
You have provided details about your lifestyle and based on this information we would like to invite you to take part in the UKLS trial. We want to recruit people aged 50 to 75 years old. We have chosen this age group because we believe that if lung cancer screening is shown to be worthwhile, these are the people most likely to benefit.
Do I have to take part?
No, it is up to you to decide whether or not to take part. If you decide to take part you will be given an information booklet to keep and asked to sign a consent form. You are still free to change your mind or withdraw from the trial at any time and without giving a reason. This will not affect the care you receive from your general practitioner (GP). If you decide not to take part, we will not contact you again.
What will happen to me if I take part?
You have already been asked some basic questions about smoking, your lifestyle, occupation and known health problems. If you are eligible to join the trial and would like to do so you will be invited to a recruitment clinic.
At the UKLS recruitment clinic, you will be met by the receptionist and invited to watch a DVD which will give you further information about the trial (watch this now ). You will then be met by a UKLS research nurse who will answer any questions you may have about the trial and then ask you to sign a consent form. At this point you will be enrolled into the trial.
- You will be asked to give your answers on a computer by touching the screen, which will help us to find a better way of identifying people for lung cancer screening programmes.
- You will also be asked to blow into a tube a few times (lung function tests) to look at the health of your lungs. Link : http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/COPD/COPD%20Consortium/spirometry_in_practice051.pdf
- A member of the UKLS team will take a sample of blood, a mouth swab or wash and a nose brush.
- You will be given a pot to take home so that you can return a deep cough sample, (this will be explained to you at the recruitment clinic).
- If you are a current smoker, you will be provided with information to help you stop smoking. Your visit to the recruitment clinic should take about an hour.
Your GP will be told that you are taking part in the UKLS trial.
Because we do not know whether CT scanning of the lungs will be beneficial, we need to divide those who join our trial into two groups so we can compare the results. For this reason half of the people in the trial will be in a group who are offered a CT scan of the lungs and the other group will not. In order to run the trial properly, the groups are chosen randomly by computer so neither you nor your doctor can choose which group you are put into. At the end of the trial the results of the two groups will be compared. You will find out which group you are in four weeks after you are enrolled.
In this trial we would also like to look at the effect of screening on the well-being of those who take part, so you will be asked to take part in surveys about your experience of the UKLS trial from time to time.
Regardless of whether you are in the screening or non-screening group, we will check on your health through your medical records over the next 10 years. If for some reason during the trial, you lose the capacity to consent, we will keep and use all the previously collected information and samples, but we will not contact you again with any questionnaires or follow-up appointments.
What are lung function tests?
Lung function tests (also known as pulmonary function tests) are used to look for the cause of breathing problems (like shortness of breath) and are also used to see how well treatments for breathing problems, such as asthma medicines, are working. They can be used to check for conditions such as asthma and lung tissue scarring. The tests may also be used to check whether a condition is getting worse.
Lung function tests are done by breathing into a tube under the supervision of a trained technologist.
Why have a control group?
The control group is very important if we are to find out if, overall, CT screening is beneficial. This is because whilst CT scans may detect lung cancer earlier, they also have small risks associated with them and detect abnormalities that are not cancer that may need further tests.
Are there any advantages of being in the control group?
People in the control group will have lung function tests and be offered advice about stopping smoking. As no CT scan will be done, they will not have the worry about abnormalities that are shown.
What is CT (Computed Tomography) Scanning?
If you are part of the screening group, you will have a CT scan of the lungs. This scan of the chest uses x-rays and a computer to produce pictures of the lungs (also known as CAT scanning). During the CT scan you lie down on the scanner and hold your breath for a few seconds while pictures of your lungs are taken. Your appointment should take about 15-30 minutes. All of the CT scan pictures are stored in a computer and looked at by a specialist (radiologist). You will hear about the results of your scan within 4 weeks of the scan. If no abnormalities are found, you will not need any further tests but we will contact you to fill out questionnaires so that we can find out about your future health and how you felt about being screened. If any important abnormalities are found you would be given an appointment to see a lung specialist at your local NHS hospital. The specialist may advise follow-up with another CT scan or other tests. If the lung specialist considers you to have lung cancer, they will discuss treatment options with you. Your GP will be kept informed of your participation in the UKLS trial and of all scan results and any treatment recommendations, and would be able to discuss them with you.
What are the possible side effects of CT scans?
Because CT scanning uses x-rays to obtain pictures, you would be exposed to some radiation which you would otherwise not receive. However, the dose of x-rays used for the screening CT scan is low (less than you normally receive in a year from the natural surrounding environment) and the risk of it causing harm is therefore very low. If an abnormality is detected, you may need follow-up CT scans and if lung cancer is strongly suspected, further tests will be required. The radiation dose for follow-up CT scans would be higher than for the first but the risk is still low and the benefits of detecting lung cancer at an early stage must be considered.
When do I get my CT results and what do they mean?
You should receive a results letter from the UKLS trials team within four weeks of having your CT scan. There are three types of results that you could receive;
- A normal result means no tumour or nodule was found. Most people will receive a normal result. A normal result does not guarantee that you do not have or will never develop lung cancer in the future, so being aware of any future symptoms of lung cancer is very important.
- An unclear result means that your screening CT scan was not quite normal and further tests are needed. Getting an unclear result may not mean you have cancer, just that you will most likely need a follow-up CT scan. If you receive an unclear result you will be invited back to the hospital to have another CT scan. Most people will then receive a normal result.
- An abnormal result means that the CT scan may have found signs of a cancerous nodule in your lungs. It is not a diagnosis of cancer, but it does mean that you will be offered a follow-up CT scan and other test.
What happens if my CT scan finds something?
You will be cared for through the NHS and given an appointment with a lung cancer specialist doctor to discuss having a more detailed examination of your lungs. Further tests may include further scans and a procedure to obtain a piece of tissue from the area of abnormality (a biopsy). If lung cancer is found, a doctor will discuss treatment options with you and your wishes will be taken into account. If you have to any tests or treatment, we will collect any left-over tissue samples or bronchial washings for future research.
How reliable is lung cancer screening?
In some cases lung cancer could be present but may not be found by CT scanning. Cancers in the main airways in the middle of the chest may be difficult to identify on CT and not all small cancers in the lung are recognised, even by the most skilled radiologists.
Are there any risks if I take part?
Sometimes non-cancerous abnormalities are found by screening which you would otherwise have never known about. If you need an operation to remove a lung abnormality or need to have a lung biopsy any possible risks will be fully explained to you by an NHS specialist before the procedure is undertaken.
What are the possible benefits of taking part?
As we do not know whether early diagnosis of lung cancer with CT scanning will be beneficial, it is not possible to tell you whether you are likely to benefit from entering the trial or not. If the trial is of no benefit to you personally because you have normal lungs it may benefit others taking part in the UKLS trial, as well as people in the future.
What happens if new information becomes available during the trial?
Sometimes during the course of a research study a new technique or new information becomes available which is relevant to the study. This is unlikely to happen in this trial because the type of CT scanner being used will be up to date and of high quality. However, should such a situation arise, the research nurse will tell you about it and discuss with you whether you wish to continue in the study or whether it would be in your best interests to withdraw.
What happens when the trial stops?
Your records will be under the care of the trial centre for 20 years and your GP will continue your normal care during and after the trial.
What will happen to the results of the trial?
The main results of this trial are not likely to be available for several years but early results relating to the number of lung cancers found by screening should be known after the first two years. Once carefully analysed, the results will be published in medical journals. If you would like a summary of the results as they become available please inform the research nurse at your trial centre.
Will my samples be used for any further research?
If you agree to take part in this trial you will be asked to give a blood sample, a sample of spit, a mouth swab or wash and a nose brush. These samples will be stored at the University of Liverpool Biobank and will be used in future research projects with ethical approval. This may allow researchers to identify biological and genetic factors that affect the risk of future lung disease. This may be useful in developing future screening tests or in understanding more about the causes of lung cancer or other lung diseases. The UKLS research team will be responsible for keeping the samples safely and making sure that any information is kept confidential. Results of any studies undertaken on your sample will not be fed back to you personally or placed in your medical records, as the tests are for research only. The research results will not have any implications for you personally. All future use of the samples will have to be approved by an Ethics Committee.
Will my taking part in the trial be kept confidential?
If you consent to take part in this trial, your medical records and CT scan results may be inspected by authorised representatives within the trial and by the Department of Health regulatory authorities. Your name will not be disclosed outside the trial. You will not be identified in any publication or report of the trial.
Who has reviewed the trial?
The trial has been reviewed by the Department of Health – Health Technology Agency, the Multi-Centre Research Ethics Committee (MREC) and by the Local Research Ethics Committees of the two centres involved.
I am a smoker but would like to stop smoking. Can I still take part?
We would encourage you to stop smoking, however if you would like to stop smoking at any point you are still able to take part in the trial. Just let us know the date you stopped smoking when you send back your next follow-up questionnaire. The UKLS team will provide you with NHS stop smoking materials or you can contact the NHS on 0800 022 4 332 or go to
What if I develop symptoms of lung cancer during the trial?
As part of the trial you will be asked about symptoms that could be due to lung cancer. If you develop symptoms such as a persistent cough for more that 3 weeks or coughing up blood, you should see your GP urgently. This applies to both screened and non-screened groups. See the following web site for full list of warning symptoms of lung cancer.
Where is the trial taking place?
There are two centres taking part in the trial:
1. The Liverpool Heart & Chest Hospital NHS Foundation Trust, Thomas Drive, Liverpool, L14 3PE;
2. Papworth Hospital NHS Foundation Trust, Papworth Everard, Cambridge, CB23 3RE.
Both centres have dedicated rooms for the trial. When you arrive, you will be directed to a waiting room and met by the trial receptionist. If you attend the Papworth clinic, you might be offered screening in our on-site mobile screening unit. There may be some support available for reasonable travel expenses in circumstances of financial difficulties. You should contact the research team during your visit to discuss this if needed.
Where can I get more information?
Please feel free to telephone the research nurse on
Liverpool XXXX between YY Hrs and ZZ Hrs
Papworth XXXX between YY Hrs and ZZ Hrs
if you would like more information or have questions you would like to ask.
What should I do now?
We hope that you are encouraged to join the trial. If you would like to take part, please return the enclosed ‘I want to participate in the UKLS questionnaire’. If however you decide not to take part, please fill in the questionnaire called ‘Not wishing to participate in the UKLS trial’.